ELITE PHARMACEUTICALS INC /NV/

ELTP | OTC | CIK: 0001053369 | SIC: 2834 Pharmaceutical Preparations | active
1 ITEM 1A RISK FACTORS 16 ITEM 1B UNRESOLVED STAFF COMMENTS 43 ITEM 1C CYBERSECURITY 43 ITEM 2 PROPERTIES 44 ITEM 3 LEGAL PROCEEDINGS 44 ITEM 4 MINE SAFETY DISCLOSURES 44 PART II 45 ITEM 5 MARKET FOR COMPANYS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 45 ITEM 6 RESERVED 46 ITEM 7 MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION 47 ITEM 7A QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 52 ITEM 8 FINANCIAL STA...

SEC Filings

View all SEC EDGAR filings: EDGAR Company Page

Structured filing index: /api/company/ELTP/filings

Origin — Data Provenance
This profile was extracted from SEC EDGAR filings (PEM-signed by sec.gov).
Every API response includes a cryptographic origin leaf for chain-of-custody tracking.
AI Discovery Document | Registry Metrics | GitHub